The stock of MBAC Fertilizer Corp (CVE:MBC) reached all time high today, Nov, 28 and still has $2.99 target or 3.00% above today’s $2.90 share price. This indicates more upside for the $5.28 million company. This technical setup was reported by Barchart.com. If the $2.99 PT is reached, the company will be worth $158,400 more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events. About 6,017 shares traded hands. MBAC Fertilizer Corp (CVE:MBC) has risen 6.00% since October 29, 2016 and is uptrending. It has underperformed by 0.01% the S&P500.
More notable recent MBAC Fertilizer Corp (CVE:MBC) news were published by: Marketwatch.com which released: “TSX Delisting Review – MBAC Fertilizer Corp. (symbol:MBC MBC.WT)” on April 06, 2016, also Marketwatch.com with their article: “MBAC Fertilizer Corp.” published on November 16, 2016, Marketwatch.com published: “TSX Delisting Review – MBAC Fertilizer Corp. (symbol:MBC and MBC.WT)” on June 24, 2016. More interesting news about MBAC Fertilizer Corp (CVE:MBC) were released by: Reuters.com and their article: “BRIEF-MBAC Fertilizer announces court approval of Brazilian restructuring …” published on September 07, 2016 as well as Benzinga.com‘s news article titled: “MBAC Fertilizer Corp. Acquires Shares of GB Minerals Ltd.” with publication date: October 29, 2016.
MBAC Fertilizer Corp. is a Canada-based company, which is engaged in the mining, production and exploration of phosphate fertilizers in the Brazilian market. The company has a market cap of $5.28 million. The Firm operates the Itafos Arraias Single Super Phosphate Operations. It currently has negative earnings. The Company’s divisions include Operations, Development and Exploration, and Corporate.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.